project: cardiodx

CardioDX logo

Connect with a Sales Specialist

x

Corus CAD

Corus CAD is the only blood test that, along with a clinical assessment, can quickly, accurately, and safely help clinicians rule out obstructive coronary artery disease (CAD) in symptomatic patients.

For Clinicians For Patients

Women and Heart Disease

CAD, one of the most common types of heart disease, can be difficult to diagnose in women. The Corus CAD blood test can help clinicians assess the likelihood that obstructive CAD is the cause of chest discomfort or other symptoms in stable, female patients.

Read more

What's New?

ABC 7 Eyewitness News, Chicago
November 02, 2016

The best way to test heart health used to be things like an echocardiogram or stress test. But doctors say false positives are extremely common...

Read more

MD Magazine
July 14, 2016

The current diagnostic pathway for evaluating chest pain patients with suspected coronary artery disease (CAD) is fraught with numerous challen...

Read more

MD+DI
April 04, 2016

The Corus CAD blood test from CardioDx has new data to back its predictive powers. In a new substudy, Corus CAD, which is used to test patients...

Read more

Fox News
March 02, 2016

For those experiencing non-urgent symptoms, there is a simple sex-specific blood test called Corus CAD -- which is especially beneficial for wo...

Read more

The Washington Post
February 22, 2016

Where men and women differ is how they respond to heart disease and how they manifest symptoms. Roughly two-thirds of women who suddenly die of...

Read more

Press Releases

November 14, 2016
CardioDx Announces Final Endpoint Results from the PRESET Registry at the AHA Scientific Sessions 2016

Read more

June 01, 2016
Khush F. Mehta Joins CardioDx as Chief Executive Officer

Read more

April 04, 2016
PROMISE Trial Substudy Demonstrates That The Corus CAD Blood Test Is Associated With Clinical Events Among Patients Being Evaluated for Suspected Obstructive Coronary Artery Disease

Read more

March 02, 2016
Commentary in The American Journal of Medicine Reinforces the Value of the Corus CAD Test in Evaluating Symptomatic Patients With Suspected Obstructive Coronary Artery Disease

Read more

December 14, 2015
Timothy Henn, Experienced Genomics Diagnostics and Life Sciences Executive, Joins CardioDx as Chief Financial Officer

Read more